Edigene CEO on Gene Editing Biotech’s Ambitious Expansion Plans
Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in gene editing treatments and…
Tagged with CAR-T
In Profile: Stéphane De Wit, A Pioneer in HIV Research
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in Brussels since 1983. Initially planning…
Ameet Mallik – EVP, Head of US, Novartis Oncology
Ameet Mallik, Executive VP and Head of Oncology for the US at Novartis Oncology highlights the company’s culture of ‘curious, inspired,…
Novartis: CAR-T’s Journey to Market in Europe
Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s European head of cell and gene…
Emanuele Ostuni – Head of Europe, Cell & Gene Therapy,…
Emanuele Ostuni, Novartis Oncology’s head of cell and gene therapy for Europe, gives an overview of the introduction of the company’s CAR-T…
Stéphane De Wit – Head, Department of Infectious Diseases,…
Professor Stéphane De Wit, head of the Department of Infectious Diseases at St Pierre University Hospital outlines Belgium’s approach to tackling…
Sandra Sanchez-Oldenhage – General Manager NoLA Region,…
Sandra Sanchez-Oldenhage, General Manager Novartis Oncology North Latin America (NoLa) Region, outlines her concerns regarding access to innovation in…
Martin Puchwein – Country President & General Manager…
Martin Puchwein, country president for Novartis Group Czech Republic, and general manager for pharma, shares his perspectives on launching innovative…
Pavel Brezina – Managing Director of Czech Republic &…
Pavel Brezina, who led the establishment of Gilead’s affiliate in the Czech Republic and Slovakia seven years ago, shares the amazing journey of…
Zhang Yu – CEO, Aeon Therapeutics, China
Dr. Zhang Yu, CEO of Aeon Therapeutics, shares the unique journey that motivated him to establish Aeon Therapeutics, as a joint venture of Chinese…
Three CAR-T Companies to Watch in China
With proactive government support and an increasingly specialised workforce, China has become one of the leading nations in the development of…
China’s CARsgen Therapeutics Wins US FDA Orphan Drug…
The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics’ CAR-T cell therapy CT053 for multiple…
